Abstract
Growth of abdominal aortic aneurysms (AAA), localized aortal wall expansions, is driven by the disruption and subsequent loss of aortal wall elastic fibers by matrix metalloproteases (MMPs). Since elastic fibers do not naturally regenerate or repair, arresting/reversing AAA growth has not been possible. Previously, we showed utility of doxycycline (DOX), an MMP inhibitor drug, to stimulate elastic matrix neoassembly and crosslinking at low microgram per milliliter doses in addition to inhibiting MMPs. We currently show in aneurysmal smooth muscle cell (SMC) cultures that effects of exogenous DOX in this dose range are linked to its upregulation of transforming growth factor beta (TGF-β1) via its inhibition of the regulatory protein c-Jun-N-terminal kinase 2 (JNK 2). We have identified a DOX dose range that stimulates elastogenesis and crosslinking without adversely impacting cell viability. Using JNK 2 inhibition as a metric for pro-regenerative matrix effects of DOX, we further demonstrate that sustained, steady-state release of DOX at the useful dose, from poly(ethylene glycol)-poly(lactic glycolic acid) nanoparticles (NPs), provides pro-elastogenic and anti-proteolytic effects that could potentially be more pronounced than that of exogenous DOX. We attribute these outcomes to previously determined synergistic effects provided by cationic amphiphile groups functionalizing the polymer NP surface. Released DOX inhibited expression and phosphorylation of JNK to likely increase expression of TGF-β1, which is known to increase elastogenesis and lysyl oxidase-mediated crosslinking of elastic matrix. Our results suggest that JNK inhibition is a useful metric to assess pro-elastic matrix regenerative effects and point to the combinatorial regenerative benefits provided by DOX and cationic-functionalized NPs.
Similar content being viewed by others
References
Aziz F, Kuivaniemi H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. Ann Vasc Surg. 2007;21:392–401.
Lu H, Rateri DL, Bruemmer D, Cassis LA, Daugherty A. Novel mechanisms of abdominal aortic aneurysms. Curr Atheroscler Rep. 2012;14:402–12.
Hobeika MJ, Thompson RW, Muhs BE, Brooks PC, Gagne PJ. Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg. 2007;45:849–57.
Aggarwal S, Qamar A, Sharma V, Sharma A. Abdominal aortic aneurysm: a comprehensive review. Exp Clin Cardiol. 2011;16:11.
Solomon CG, Kent KC. Abdominal aortic aneurysms. N Engl J Med. 2014;371:2101–8.
Gacchina CE, Deb P, Barth JL, Ramamurthi A. Elastogenic inductability of smooth muscle cells from a rat model of late stage abdominal aortic aneurysms. Tissue Eng Part A. 2011;17:1699–711.
Sivaraman B, Ramamurthi A. Multifunctional nanoparticles for doxycycline delivery towards localized elastic matrix stabilization and regenerative repair. Acta Biomater. 2013;9:6511–25.
Johnson DJ, Robson P, Hew Y, Keeley FW. Decreased elastin synthesis in normal development and in long-term aortic organ and cell cultures is related to rapid and selective destabilization of mRNA for elastin. Circ Res. 1995;77:1107–13.
Prall AK, Longo GM, Mayhan WG, Waltke EA, Fleckten B, Thompson RW, et al. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice. J Vasc Surg. 2002;35:923–9.
Yoshimura K, Aoki H, Ikeda Y, Furutani A, Hamano K, Matsuzaki M. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase in mice. Ann N Y Acad Sci. 2006;1085:74–81.
Wu S, Kasisomayajula K, Peng J, Bancalari E. Inhibition of JNK enhances TGF-β1-activated Smad2 signaling in mouse embryonic lung. Pediatr Res. 2009;65:381–6.
Kothapalli CR, Ramamurthi A. Lysyl oxidase enhances elastin synthesis and matrix formation by vascular smooth muscle cells. J Tissue Eng Regen Med. 2009;3:655–61.
Ventura J-J, Kennedy NJ, Flavell RA, Davis RJ. JNK regulates autocrine expression of TGF-β1. Mol Cell. 2004;15:269–78.
Jennewine B, Fox J, Ramamurthi A. Cathepsin K-targeted sub-micron particles for regenerative repair of vascular elastic matrix. Acta Biomater. 2017;52:60–73.
Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980;102:344–52.
Igoucheva O, Alexeev V, Halabi CM, Adams SM, Stoilov I, Sasaki T, et al. Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities. J Biol Chem. 2015;290:21443–59.
Starcher B. A ninhydrin-based assay to quantitate the total protein content of tissue samples. Anal Biochem. 2001;292:125–9.
McMahon MP, Faris B, Wolfe BL, Brown KE, Pratt CA, Toselli P, et al. Aging effects on the elastin composition in the extracellular matrix of cultured rat aortic smooth muscle cells. Vitro Cell Dev Biol-Plant. 1985;21:674–80.
Sho E, Chu J, Sho M, Fernandes B, Judd D, Ganesan P, et al. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms. J Vasc Surg. 2004;39:1312–21.
Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg. 2000;31:325–42.
Ding R, McGuinness CL, Burnand KG, Sullivan E, Smith A. Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline. Vascular. 2005;13:290–7.
Bendeck MP, Conte M, Zhang M, Nili N, Strauss BH, Farwell SM. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol. 2002;160:1089–95.
Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med. 2005;11:1330–8.
Dodd BR, Spence RA. Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature. Curr Vasc Pharmacol. 2011;9:471–8.
Daugherty A, Cassis LA. Mouse models of abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol. 2004;24:429–34.
AAssar OS, Fujiwara NH, Marx WF, Matsumoto AH, Kallmes DF. Aneurysm growth, elastinolysis, and attempted doxycycline inhibition of elastase-induced aneurysms in rabbits. J Vasc Interv Radiol JVIR. 2003;14:1427–32.
Halpern VJ, Nackman GB, Gandhi RH, Irizarry E, Scholes JV, Ramey WG, et al. The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response. J Vasc Surg. 1994;20:51–60.
Newman KM, Jean-Claude J, Li H, Ramey WG, Tilson MD. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation. 1994;90:II224–7.
Franco C, Ho B, Mulholland D, Hou G, Islam M, Donaldson K, et al. Doxycycline alters vascular smooth muscle cell adhesion, migration, and reorganization of fibrillar collagen matrices. Am J Pathol. 2006;168:1697–709.
Ahler E, Sullivan WJ, Cass A, Braas D, York AG, Bensinger SJ, et al. Doxycycline alters metabolism and proliferation of human cell lines. Samant R, editor. PLoS ONE. 2013;8:e64561.
Leask A, Holmes A, Black CM, Abraham DJ. Connective tissue growth factor gene regulation: requirements for its induction by transforming growth factor-2 in fibroblasts. J Biol Chem. 2003;278:13008–15.
Losy F, Dai J, Pages C, Ginat M, Muscatelli-Groux B, Guinault A-M, et al. Paracrine secretion of transforming growth factor-β1 in aneurysm healing and stabilization with endovascular smooth muscle cell therapy. J Vasc Surg. 2003;37:1301–9.
Dai J. Overexpression of transforming growth factor-1 stabilizes already-formed aortic aneurysms: a first approach to induction of functional healing by endovascular gene therapy. Circulation. 2005;112:1008–15.
DiMusto PD, Lu G, Ghosh A, Roelofs KJ, Sadiq O, McEvoy B, et al. Increased JNK in males compared with females in a rodent model of abdominal aortic aneurysm. J Surg Res. 2012;176:687–95.
Kagan HM, Tseng L, Simpson DE. Control of elastin metabolism by elastin ligands. Reciprocal effects on lysyl oxidase activity. J Biol Chem. 1981;256:5417–21.
Kagan HM, Sullivan KA, Olsson TA, Cronlund AL. Purification and properties of four species of lysyl oxidase from bovine aorta. Biochem J. 1979;177:203–14.
Tezvergil-Mutluay A, Agee KA, Uchiyama T, Imazato S, Mutluay MM, Cadenaro M, et al. The inhibitory effects of quaternary ammonium methacrylates on soluble and matrix-bound MMPs. J Dent Res. 2011;90:535–40.
Sah H, Desu HR, Sah E, Wood GC, Thoma LA. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int J Nanomedicine. 2013;8:747.
Vonarbourg A, Passirani C, Saulnier P, Benoit J-P. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials. 2006;27:4356–73.
Labhasetwar V, Song C, Humphrey W, Shebuski R, Levy RJ. Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci. 1998;87:1229–34.
Sperelakis N. Origin of resting membrane potentials. In: Sperelakis N, editor. Cell physiology source book: essentials of membrane biophysics. 4th ed. San Diego: Academic Press; 2011. pp. 121–145.
Thote AJ, Chappell JT, Gupta RB, Kumar R. Reduction in the initial-burst release by surface crosslinking of PLGA microparticles containing hydrophilic or hydrophobic drugs. Drug Dev Ind Pharm. 2005;31:43–57.
Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res. 2004;27:1–12.
Tamada JA, Langer R. Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci. 1993;90:552–6.
Mendis E, Kim M-M, Rajapakse N, Kim S-K. The inhibitory mechanism of a novel cationic glucosamine derivative against MMP-2 and MMP-9 expressions. Bioorg Med Chem Lett. 2009;19:2755–9.
Acknowledgements
The authors acknowledge funding support for this work from the National Science Foundation (1508642), American Heart Association (16IRG27250113), and the National Institutes of Health (HL132856), awarded to A.R. The authors would also like to acknowledge Ms. Mei Yin at the Biomedical Imaging Core at the Lerner Research Institute of the Cleveland Clinic for her assistance with the TEM imaging performed in this study. This work utilized the Leica SP8 confocal microscope that was purchased with funding from National Institutes of Health SIG grant 1S10OD019972-01. This work also utilized the FEI Tecnai G2 Spirit transmission electron microscope that was purchased with funding from National Institutes of Health SIG grant 1S10RR031536-01.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
Andrew Camardo and Dhruv Seshadri designate co-authorship.
Rights and permissions
About this article
Cite this article
Camardo, A., Seshadri, D., Broekelmann, T. et al. Multifunctional, JNK-inhibiting nanotherapeutics for augmented elastic matrix regenerative repair in aortic aneurysms. Drug Deliv. and Transl. Res. 8, 964–984 (2018). https://doi.org/10.1007/s13346-017-0419-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13346-017-0419-y